©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6448-6456
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6448
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6448
Table 1 Clinical and pathological features of Epstein-Barr virus-associated gastric carcinoma
| Clinical and pathological features | |
| Age | Younger1 |
| Gender | Male predominance |
| Associations | Smoking |
| Prevalence | 10% of gastric carcinoma cases |
| Location | Gastric body/cardia |
| Remnant stomach | |
| Clinical | Multiple carcinomas1 |
| Thickening of gastric wall | |
| Ulcerated (saucer-like) neoplasm | |
| Lower rate of lymph node involvement1 | |
| Histology | Lymphoepithelioma-like |
| Lymphocytic infiltration in various degrees | |
| Atrophic gastritis | |
| Lace pattern within the mucosa | |
| Moderate to poorly differentiated adenocarcinoma | |
| Prognosis | Longer survival1 |
- Citation: Yau TO, Tang CM, Yu J. Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments. World J Gastroenterol 2014; 20(21): 6448-6456
- URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6448.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6448